Personalized medicine with IgGAM compared with standard of care for treatment of peritonitis after infectious source control (the PEPPER trial): study protocol for a randomized controlled trial. [electronic resource]
Producer: 20190626Description: 156 p. digitalISSN:- 1745-6215
- Anti-Bacterial Agents -- therapeutic use
- Austria
- Biomarkers -- blood
- Clinical Decision-Making
- Germany
- Humans
- Immunoglobulin A -- administration & dosage
- Immunoglobulin G -- administration & dosage
- Immunoglobulin M -- administration & dosage
- Immunoglobulins, Intravenous -- administration & dosage
- Immunotherapy -- adverse effects
- Infusions, Intravenous
- Multicenter Studies as Topic
- Patient Selection
- Peritonitis -- diagnosis
- Precision Medicine -- adverse effects
- Predictive Value of Tests
- Prospective Studies
- Randomized Controlled Trials as Topic
- Sepsis -- diagnosis
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial Protocol; Journal Article
There are no comments on this title.
Log in to your account to post a comment.